however, they were among the least effective in preserving lean mass, with lean mass loss contributing to approximately 25% of total weight reduction
Clinical trials (SURPASS programme) have shown that this dual-receptor approach provides effective glycaemic control
During a 2021 trial of a higher dose of semaglutide 2.4mg, like Wegovy on 1,961 adults with BMIs of 30 or more for over a year, those taking semaglutide lost an average of 15% of their body weight, compared to the placebo group which lost an average of 2.4%
Risks of buying from unregulated sources When a medicine is hard to get quickly, unregulated sellers appear, often online or through social media, offering to skip the prescription
What you shouldnt do: Dont fall into the trap of thinking that newer equals betteror hang your hat on one individual piece of data